Climate-neutral wastewater treatment plants thanks to patented real-time analytics - 08/11/2023

Using AI to reduce greenhouse gases in wastewater companies

The wastewater industry is responsible for global greenhouse gas emissions equivalent to those of global aviation. The start-up Variolytics has found a way to significantly reduce greenhouse gases in wastewater treatment plants using real-time analytics. The patented sensor technology and AI-supported process optimisation offer multiple benefits: in addition to reducing nitrous oxide, the system helps to reduce energy costs and resources.

CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments are unsuccessful. A limiting factor of this very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion. Researchers at the University of Freiburg have now been able to prevent this exhaustion and thus significantly improve the effect of the therapy in a preclinical animal model.

The Sustainability Innovation Campus (ICN) initiated by the University of Freiburg and the Karlsruhe Institute of Technology (KIT), which will begin its work in January 2024, has announced a two-year funding programme for start-up projects. Scientists from the University of Freiburg, KIT and cooperating universities and research institutions are invited to submit their project outlines by 30 November 2023.

Wasser 3.0: #detect|remove|reuse - 31/10/2023

How to sustainably remove and recycle microplastics from water

We all pollute our water with things we use in our everyday lives. In the process, microplastics and micropollutants accumulate in sometimes significant quantities and are difficult to remove. This has increasingly devastating consequences for our health and the environment. Wasser 3.0, a non-profit start-up from Karlsruhe, has declared war on this problem by developing a customisable process to detect, remove and even recycle these pollutants.

An interdisciplinary research group combining mechanical engineering and biotechnology has taken up its work at the Institute for Molecular Systems Engineering and Advanced Materials (IMSEAM) of Heidelberg University. The team under the direction of Dr Kai Melde will pursue an innovative approach to biofabrication – 3D cell culture using ultrasound. Tools are being developed that can be used as an alternative to or enhancement for 3D printing.

Textiles are a given in civil engineering. Until now, textiles made of resistant synthetic fibers have been used for this purpose, having a long lifetime. For some applications, however, it would not only be sufficient but even desirable for the auxiliary textile to degrade when it has done its job. Natural fibers, in contrast, often decompose too quickly. The DITF are developing a bio-based protective coating that extends their service life.

High-resolution microscopy technology bypassing the diffraction limit - 26/10/2023

From micro- to nanoscope

It has long been impossible to distinguish objects closer than 200 nanometres using light microscopes. However, novel devices developed by a company called abberior Instruments GmbH, which use technology developed by Nobel Prize winner Prof. Dr. Stefan Hell and his teams in Heidelberg and Göttingen, are now able to bypass this resolution limit and provide detailed insights into living cells in the lower nanometre range.

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General and Visceral Surgery at the Freiburg University Medical Center and member of the Medical Faculty at the University of Freiburg, has received a European Research Council (ERC) Starting Grant from the European Commission. Her DRESSCODE project will receive a total of 1.5 million euros funding for five years.

Epigenetically active drugs enable the cell to read parts of the genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the University Hospital Tübingen have now published. These "therapy-induced epitopes" could help the immune system recognize cancer cells.

Epigenetically active drugs enable the cell to read parts of the genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German Cancer Research Center and the University Hospital Tübingen have now published. These "therapy-induced epitopes" could help the immune system recognize cancer cells.

A researcher team from Ecole Polytechnique Federal de Lausanne led by Dr. Vivek Thacker now group leader at the Department of Infectious Diseases at Heidelberg University Hospital have studied why tuberculosis bacteria form long strands and how this affects their infectivity. Their findings could lead to new therapies and have now been published in the journal Cell.

Why are severe courses of SARS-CoV-2 infection less common in children and adolescents than in adults? Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered that the immune system in the upper respiratory tract is much more alert and active in children before infection than in adults and is therefore better equipped to fight the virus.

Microorganisms degrade biobased turf infill - 17/10/2023

Eco-friendly artificial turf: a sports pitch that’s good for people and the environment

There are thousands of artificial turf pitches in Germany. They are extremely practical, but often not at all environmentally friendly. When it rains or the pitch is used, plastic particles from the rubber granules can be released into the envronment, where they remain. Researchers at the University of Stuttgart along with the company TECNARO are now developing an artificial turf with an infill that biodegrades as soon as it leaves the pitch.

The development of highly specific T-cell engagers directed against pHLA tumor targets will be quick and easy. BioCopy's innovative pHLA screening technology characterizes drug candidates in great depth for their specific binding against the desired pHLA tumor target. YUMAB develops highly specific antibodies with their advanced antibody technologies.

The new Center for Bionic Intelligence Tübingen Stuttgart aims to optimize the interaction between humans and technical systems in a fundamentally new way. Scientists from the Universities of Stuttgart and Tübingen, the Max Planck Institute for Intelligent Systems and the Max Planck Institute for Biological Cybernetics are conducting research on intelligent bionic systems that will aid understanding and treatment of certain diseases of the CNS.

Doubling food production, saving water, and increasing carbon storage capacity – this may sound paradoxical, but would be theoretically feasible. Reaching this goal, however, would require a radical spatial reorganization of land use. This is the conclusion of researchers from Karlsruhe Institute of Technology (KIT) and the Heidelberg Institute for Geoinformation Technology (HeiGIT) of Heidelberg University.

Dossier - 11/10/2023

The quantum revolution in the healthcare industry

From ultra-fast quantum computers to highly sensitive sensors - quantum technologies could take medicine a giant step forward. Possible areas of application range from drug development and early cancer detection to reading brain waves to control prostheses or exoskeletons. The German state of Baden-Württemberg plays a key role in the development of sensors in particular.

The demand for skilled workers in Germany is high - especially in the healthcare sector. But the procedure for hiring and recognising qualifications is complex. In Baden-Württemberg, the Welcome Center Sozialwirtschaft Baden-Württemberg is one of the contact points for companies and professionals seeking advice on the process.

Researchers at the University of Hohenheim are working on an alternative to fish consisting of microalgae. Advantage: Microalgae have high quality ingredients and also contribute to carbon storage.

Preventing waste from instant meals - 05/10/2023

EDGGY: edible packaging film made from eggshell waste

Many instant meals such as ramen soups have both a protective outer packaging and individual ingredients in small plastic sachets. To prevent this environmentally harmful waste, five students at the University of Hohenheim have developed a sustainable film based on eggshells and plant proteins that dissolves in hot water and is edible.

A phase I clinical trial is now starting at Tuebingen University Hospital in the Clinical Collaboration Unit (CCU) Translational Immunology, in collaboration with the Department of Internal Medicine I, which is investigating the therapeutic cancer peptide vaccine Fusion-VAC-XS15 in combination with immune checkpoint blockade by atezolizumab (Tecentriq®).

A research team of scientists from the Fraunhofer IPA, the Bosch Digital Innovation Hub at Bosch Health Campus and the Institute of Image-Guided Surgery (IHU) of Strasbourg has jointly launched the DAIOR project. Within the framework of the project, the project partners are working on realizing the operating room of the future with help of artificial intelligence and robot assisted telemedicine.